The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of gefitinib combined with bevacizumab versus gefitinib in advanced EGFR L858R NSCLC.
 
Xinmin Zhao
No Relationships to Disclose
 
Xianghua Wu
No Relationships to Disclose
 
Huijie Wang
No Relationships to Disclose
 
Hui Yu
No Relationships to Disclose
 
Si Sun
No Relationships to Disclose
 
Yu Feng
No Relationships to Disclose
 
Jialei Wang
No Relationships to Disclose